Genetic aspects and research development in haemostasis. - Wikidata - wikimedia - TriplyDB

Genetic aspects and research development in haemostasis.

Genetic aspects and research development in haemostasis.

http://www.wikidata.org/entity/Q37176521

about

Perinatal gene transfer to the liver.Unique strategies for therapeutic gene transfer in haemophilia A and haemophilia BWFH State-of-the-Art Session on Therapeutic Gene Transfer Buenos Aires, Argentina.

P2860

Q35238390-84295CD4-F653-44CF-82C4-4F1A83AEAF7A Q37768868-7A2D8FB9-A725-469E-9944-048B20DD50E2

P2860

Genetic aspects and research development in haemostasis.

http://www.wikidata.org/entity/Q37176521

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on July 2008

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Genetic aspects and research development in haemostasis.

@en

Genetic aspects and research development in haemostasis.

@nl

type

label

Genetic aspects and research development in haemostasis.

@en

Genetic aspects and research development in haemostasis.

@nl

prefLabel

Genetic aspects and research development in haemostasis.

@en

Genetic aspects and research development in haemostasis.

@nl

P1433

Q37176521-B2B8851B-7B62-479F-BA21-A9D5753E8AE4

P1476

Q37176521-8D8588A8-0220-4276-A3D3-EECEA5FBB0C8

P2093

Q37176521-16841232-3718-46CF-BE6B-65C902573264

Q37176521-34E962BB-3FF1-4A01-8F20-EDD02C78383A

Q37176521-43DED6D1-4DC2-485A-9853-7CCE11FA6053

Q37176521-489E6D61-AC65-445E-9D46-5C2A35E1BCEE

Q37176521-59B4AEA0-9889-4C86-AC06-76FFD81B565F

Q37176521-81032E8E-670D-408E-B111-660B2236F2F4

Q37176521-BE8E4919-C569-417E-A508-7BDC9F703DAA

Q37176521-BF55F430-E586-42D8-B44B-6CB82C0A6129

Q37176521-FD7535A7-3D3C-4EBD-8297-42EB6A534949

P2860

Q37176521-0A8B526B-91CD-4800-8C62-A102A84149DD

Q37176521-0DE420FB-823D-4177-B3A6-824CD2ADB9A7

Q37176521-173A700F-56A0-4833-BDA7-1CFA807151A6

Q37176521-256709EE-F9C1-453F-8F66-863BB1723F3A

Q37176521-28151621-35A6-4E79-868A-468F0B9AE7AC

Q37176521-3DCB6990-5A09-4EDD-93E7-0A28946C21A4

Q37176521-5467ED37-385D-4238-874E-710440FF4BBE

Q37176521-79E5EAFD-76EA-41C6-93BC-3514A9D0B9CA

Q37176521-836F127D-B756-4DA8-A4A8-CDB597571CF8

Q37176521-C9F39AF3-32BC-4185-B609-D2A68C45FC68

P304

Q37176521-209BBAC6-7949-48E6-8980-A2FA23520F2C

P31

Q37176521-09657F10-8491-4A50-9F12-F6EFD6DFE416

P356

Q37176521-52A3F621-A410-4E7F-B218-C05E103812D8

P478

Q37176521-DC183F61-8531-4DE0-B4F5-BC0D22175CD3

P50

Q37176521-2541EDCC-DDA0-4AB5-A26E-F921021A0F5C

Q37176521-272C8F68-FA73-4517-99B9-53C3E07A78E1

Q37176521-CA53E66F-5A65-4AB5-9EA3-22CCA5DE8B54

P577

Q37176521-E9C5EE34-1491-442B-BE2F-38C11D7C994B

P5875

Q37176521-19E35CE6-C63F-4282-95E5-5F6FA41C567A

P698

Q37176521-146F57F7-B2F7-4DFA-A9E6-64F2B8B4DC95

P356

J.1365-2516.2008.01740.X

P1433

P1476

Genetic aspects and research development in haemostasis

@en

P2093

E Berntorp

http://www.w3.org/2001/XMLSchema#string

E G Tuddenham

http://www.w3.org/2001/XMLSchema#string

G Mariani

http://www.w3.org/2001/XMLSchema#string

J Ingerslev

http://www.w3.org/2001/XMLSchema#string

K Christiansen

http://www.w3.org/2001/XMLSchema#string

L Norengaard Sørensen

http://www.w3.org/2001/XMLSchema#string

M K Chuah

http://www.w3.org/2001/XMLSchema#string

S Kochanek

http://www.w3.org/2001/XMLSchema#string

T Vandendriessche

http://www.w3.org/2001/XMLSchema#string

P2860

Bleeding due to disruption of a cargo-specific ER-to-Golgi transport complex

Rare coagulation deficiencies.

Recessively inherited coagulation disorders.

Prothrombin deficiency results in embryonic and neonatal lethality in mice.

Short-term correction of factor VIII deficiency in a murine model of hemophilia A after delivery of adenovirus murine factor VIII in utero.

Permanent phenotypic correction of hemophilia B in immunocompetent mice by prenatal gene therapy.

Polymorphisms in the TNFA gene and the risk of inhibitor development in patients with hemophilia A.

Polymorphisms in the CTLA-4 gene and inhibitor development in patients with severe hemophilia A.

The Malmö International Brother Study (MIBS): further support for genetic predisposition to inhibitor development in hemophilia patients.

Results in three Australian haemophilia B patients with high-responding inhibitors treated with the Malmö model.

P304

113-118

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1365-2516.2008.01740.X

http://www.w3.org/2001/XMLSchema#string

P478

14 Suppl 3

http://www.w3.org/2001/XMLSchema#string

P50

Simon N. Waddington

Suzanne M Buckley

P577

2008-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51394112

http://www.w3.org/2001/XMLSchema#string

P698

18510530

http://www.w3.org/2001/XMLSchema#string